Katja Mohorčič

Katja Mohorčič
no.: 30985 source: ARIS

researcher – active in research organisation
  katja.mohorcicat signklinika-golnik.si
Edit
Research activity

Code Science Field Subfield
3.01.00  Medical sciences  Microbiology and immunology   
3.06.00  Medical sciences  Cardiovascular system   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
176.11
A''
69.79
A'
111.13
A1/2
142.69
CI10
257
CImax
46
h10
9
A1
0.69
A3
0.06
Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024 (2023)
Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 27  244  235  8.7 
Scopus 18  284  273  15.17 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  Medical doctor    SI University of Ljubljana, Faculty of Medicine 2004 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (100%, RD:20%)  University Clinic of Respiratory and Allergic Diseases  Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Slovene)  6/1/2007  Consultant doctor in hospital  Researcher  Trainee assistant 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. L1-60135  Circulating extracellular vesicles as a source of multi-omic biomarkers of development of asbestos-related diseases and treatment response in malignant mesothelioma   1/1/2025 - 12/31/2027  PhD Vita Dolžan   3,288 
2. J3-4516  Neoantigens in non small cell lung cancer   10/1/2022 - 9/30/2025  PhD Julij Šelb   2,319 
3. J3-7372  Molecular biomarkers and biomarker-driven therapy in lung cancer   1/1/2016 - 12/31/2018  PhD Tanja Čufer   5,007 
4. J3-3626  Genetic factors involved in imunoregulatory cells deficiency in diseases with expansion of CD4-positive Th-1 biased T cell response   5/1/2010 - 4/30/2013  PhD Peter Korošec   3,605 
Confirmation required
Views history
Favourite